Extracellular Vesicles Secreted from Cancer Cell Lines Stimulate Secretion of MMP-9, IL-6, TGF-β1 and EMMPRIN

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Redzic, Jasmina S ^a   Kendrick, Agnieszka A ^a   Bahmed, Karim ^a   Dahl, Kristin D ^a   Pearson, Chad G ^a   Robinson, William A ^a   Robinson, Steven E ^a   Graner, Michael W ^a   Eisenmesser, Elan Z ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; GELATINASE B; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL STIMULATION; CELL VACUOLE; CONTROLLED STUDY; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNE EVASION; INTERNALIZATION; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN SECRETION; SPECTROSCOPY; TUMOR MICROENVIRONMENT; UPREGULATION;

ANTIGENS, CD147; CELL LINE, TUMOR; EXTRACELLULAR SPACE; FEEDBACK, PHYSIOLOGICAL; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 9; PROTEIN TRANSPORT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84880989093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071225     Document Type: Article

References (53)

1. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L, (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78: 838-848.
2. Castellana D, Toti F, Freyssinet JM, (2010) Membrane microvesicles: macromessengers in cancer disease and progression. Thromb Res 125Suppl 2: S84-88.
3. van Kilsdonk JWJ, van Kempen LCLT, van Muijen GNP, Ruiter DJ, Swart GWM, (2010) Soluble adhesion molecules in human cancers: Sources and fates. European Journal of Cell Biology 89: 415-427.
4. Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, et al. (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68: 2667-2688.
5. Colombo E, Borgiani B, Verderio C, Furlan R, (2012) Microvesicles: novel biomarkers for neurological disorders. Front Physiol 3: 63.
6. Meckes DG Jr, Raab-Traub N, (2011) Microvesicles and viral infection. J Virol 85: 12844-12854.
7. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, et al. (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295-305.
8. Inal JM, Ansa-Addo EA, Stratton D, Kholia S, Antwi-Baffour SS, et al. (2012) Microvesicles in health and disease. Arch Immunol Ther Exp (Warsz) 60: 107-121.
9. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
10. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, et al. (2008) Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 15: 80-88.
11. Mathivanan S, Ji H, Simpson RJ, (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73: 1907-1920.
12. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, et al. (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18: 883-891.
13. Antonyak MA, Li B, Boroughs LK, Johnson JL, Druso JE, et al. (2011) Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci U S A 108: 4852-4857.
14. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, et al. (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10: 619-624.
15. Escrevente C, Keller S, Altevogt P, Costa J, (2011) Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer 11: 108.
16. Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B, et al. (2011) Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin Immunopathol 33: 455-467.
17. Bierie B, Moses HL, (2010) Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev 21: 49-59.
18. Johansson N, Ahonen M, Kahari VM, (2000) Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 57: 5-15.
19. Ara T, Declerck YA, (2010) Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer 46: 1223-1231.
20. Ford HL, Kabingu EN, Bump EA, Mutter GL, Pardee AB, (1998) Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A 95: 12608-12613.
21. Cailleau R, Olive M, Cruciger QV, (1978) Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14: 911-915.
22. Sundstrom C, Nilsson K, (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17: 565-577.
23. Bahmed K, Henry C, Holliday M, Redzic JS, Ciobanu M, et al. (2012) Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B. Cancer Cell Int. 12: 19.
24. Marusyk A, Wheeler LJ, Mathews CK, DeGregori J, (2007) p53 mediates senescence-like arrest induced by chronic replicational stress. Mol Cell Biol 27: 5336-5351.
25. Bruns CJ, Harbison MT, Kuniyasu H, Eue I, Fidler IJ, (1999) In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1: 50-62.
26. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470-1476.
27. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL, (2010) Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One 5: e11469.
28. Lopez-Verrilli MA, Court FA, (2013) Exosomes: mediators of communication in eukaryotes. Biol Res 46: 5-11.
29. Zhong WD, Han ZD, He HC, Bi XC, Dai QS, et al. (2008) CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology 75: 230-236.
30. Hong DS, Angelo LS, Kurzrock R, (2007) Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110: 1911-1928.
31. Tang Y, Kesavan P, Nakada MT, Yan L, (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2: 73-80.
32. Huet E, Gabison EE, Mourah S, Menashi S, (2008) Role of emmprin/CD147 in tissue remodeling. Connect Tissue Res 49: 175-179.
33. Redzic JS, Armstrong GS, Isern NG, Jones DN, Kieft JS, et al. (2011) The retinal specific CD147 Ig0 domain: from molecular structure to biological activity. J Mol Biol 411: 68-82.
34. Filipazzi P, Burdek M, Villa A, Rivoltini L, Huber V, (2012) Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 22: 342-349.
35. Xiang X, Poliakov A, Liu C, Liu Y, Deng ZB, et al. (2009) Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer 124: 2621-2633.
36. Zwaagstra JC, El-Alfy M, O'Connor-McCourt MD, (2001) Transforming growth factor (TGF)-beta 1 internalization: modulation by ligand interaction with TGF-beta receptors types I and II and a mechanism that is distinct from clathrin-mediated endocytosis. J Biol Chem 276: 27237-27245.
37. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C, (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123: 1603-1611.
38. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, et al. (2006) Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 55: 808-818.
39. Sidhu SS, Mengistab AT, Tauscher AN, LaVail J, Basbaum C, (2004) The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 23: 956-963.
40. Keller S, Konig AK, Marme F, Runz S, Wolterink S, et al. (2009) Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett 278: 73-81.
41. Breakefield XO, Frederickson RM, Simpson RJ, (2011) Gesicles: Microvesicle "cookies" for transient information transfer between cells. Mol Ther 19: 1574-1576.
42. Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3: Unit 3 22.
43. Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, et al. (2012) Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56: 293-304.
44. Taylor DD, Zacharias W, Gercel-Taylor C, (2011) Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol 728: 235-246.
45. Geissmann F, Jung S, Littman DR, (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
46. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, et al. (1997) Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27: 431-441.
47. Mellman I, Steinman RM, (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
48. Kleiner DE, Stetler-Stevenson WG, (1999) Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43Suppl: S42-51.
49. Yu W, Liu J, Xiong X, Ai Y, Wang H, (2009) Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathol Res Pract 205: 709-715.
50. Deryugina EI, Quigley JP, (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34.
51. Coussens LM, Werb Z, (1996) Matrix metalloproteinases and the development of cancer. Chem Biol 3: 895-904.
52. Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, et al. (2005) High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res 11: 5158-5166.
53. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.